A blood test based on whole-genome sequencing achieved 99% sensitivity and specificity for detecting HPV-positive head and neck cancer. Early postoperative detection of circulating tumor DNA predicted ...

Testing for high-risk human papillomaviruses every five years – even with a self-collected sample – is the “preferred screening strategy” for cervical cancer starting at age 30, according to a new ...

Head and neck cancer researchers are reporting the development and testing of HPV-DeepSeek, a novel liquid biopsy assay. In their new study, HPV-DeepSeek achieved 99% sensitivty and specifity for ...

Raise your hand if you've ever procrastinated getting your Pap smear. While it's a crucial part of testing for HPV and cervical cancer, the test can range from uncomfortable to downright painful.

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A new blood test can identify cancers of the head and neck caused by ...

Making human papillomavirus (HPV) self-testing available to all women increases the number of people screened for cervical cancer, a new study led by researchers from Te Herenga Waka—Victoria ...

Mitchell is an associate professor at the University of Virginia and an NIH-funded nurse scientist. Kueter, a former health journalist and public radio reporter, works as a magazine editor at UVA ...

Medicare Part B generally covers HPV tests every five years for individuals ages 30–65 without symptoms, as part of a Pap test. Individuals over 65 may not need regular HPV testing if previous results ...

Regular cervical cancer screening using HPV testing and/or Pap tests can prevent up to 90% or more of cervical cancers by detecting and treating precancerous lesions early, making it one of the most ...

NEW DELHI: As India rolls out its national HPV vaccination campaign, researchers from AIIMS New Delhi, ICMR institutes and the WHO's International Agency for Research on Cancer (IARC), France, have ...